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Peptide:glycosaminoglycan hybrid hydrogels as an
injectable intervention for spinal disc
degeneration†‡
D. E. Miles,ab E. A. Mitchell,ac N. Kapur,d P. A. Beales*be and R. K. Wilcox*ad
Degeneration of the spinal discs is a major cause of back pain. During the degeneration process, there
is a loss of glycosaminoglycans (GAGs) from the proteoglycan-rich gel in the disc’s nucleus, which
adversely alters biomechanical performance. Current surgical treatments for back pain are highly
invasive and have low success rates; there is an urgent need for minimally-invasive approaches that
restore the physiological mechanics of the spine. Here we present an injectable peptide:GAG hydrogel
that rapidly self-assembles in situ and restores the mechanics of denucleated intervertebral discs.
It forms a gel with comparable mechanical properties to the native tissue within seconds to minutes
depending on the peptide chosen. Unlike other biomaterials that have been proposed for this purpose,
these hybrid hydrogels can be injected through a very narrow 25 G gauge needle, minimising damage
to the surrounding soft tissue, and they mimic the ability of the natural tissue to draw in water by
incorporating GAGs. Furthermore, the GAGs enhance the gelation kinetics and thermodynamic stability
of peptide hydrogels, significantly reducing eﬀusion of injected material from the intervertebral disc
(GAG leakage of 8  3% after 24 h when peptide present, compared to 39  3% when no peptide
present). In an ex vivo model, we demonstrate that the hydrogels can restore the compressive stiﬀness
of denucleated bovine intervertebral discs. Compellingly, this novel biomaterial has the potential to
transform the clinical treatment of back pain by resolving current surgical challenges, thus improving
patient quality of life.
Introduction
Back pain, especially in the lower spine, is strongly associated
with degeneration of the intervertebral discs, the soft tissue
between the vertebrae that allow their articulation. Current
surgical treatments for disc degeneration are highly invasive
and have low success rates. With total healthcare and social
costs for back pain currently exceeding 1% of GDP in many
industrialised nations, there is an urgent social and economic
need for more eﬀective therapies that relieve pain and restore
the physiological mechanics of the spine.1–3
The intervertebral disc is a complex hierarchical structure
comprising an outer annulus fibrosus and inner gel-like nucleus
pulposus (Fig. 1). The nucleus has a high concentration of
proteoglycan macromolecules, which play an important role in
the mechanical function of the disc. The glycosaminoglycan
(GAG) side chains of the proteoglycans, predominantly chon-
droitin sulphate, arranged in a comb like structure, provide a
fixed negative charge, which causes an influx of small cations
into the nucleus. This high salt content results in an osmotic
pressure within the disc that provides resistance to compressive
loading. One of the main compositional changes during disc
degeneration is a decrease in size and quality of the proteoglycan
aggregates within the nucleus, which causes the vital glycosamino-
glycans (GAGs) to leach out, resulting in a loss of hydration and
swelling pressure.4–6 It is this reduction in swelling pressure and
the consequent changes in the biomechanics of the spine that can
cause disc height loss and nerve impingement, ultimately leading
to back pain.
One potential therapy to restore biomechanical function
to the degenerated disc is to augment or replace the nucleus.7
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The use of synthetic hydrogels has been explored for this
purpose, particularly because their hydrophilic nature can mimic
the transport and biomechanical properties of the natural tissue.8
However, to date they have had limited clinical success due to
their insuﬃcient mechanical properties and extrusion from the
treatment site.7–9
Self-assembling peptides have many potential biomedical
applications.10–13 Stimuli-responsive self-assembly and gelation
of peptide nanomaterials enables them to be introduced mini-
mally invasively.14–17 Furthermore, they can be designed with
a wide range of chemical and mechanical properties18–20 that
could be advantageous for application in nucleus augmentation.
Recently, composite hydrogels have been investigated, which aim
to supplement or enhance the intrinsic functional properties of
these peptide-based materials.21,22
The Leeds peptide group have designed a plethora of de novo
b-sheet tape forming peptides, which self-assemble in one
dimension into a hierarchy of well defined structures.23,24 They
are advantageous because they are based entirely upon natural
amino acids and their self-assembly can be triggered by external
factors such as pH, ionic strength and temperature.25–27
In this work, we investigate whether such a peptide could be
optimised for nucleus augmentation applications. Since the func-
tion of the intervertebral disc is dependent on the GAG content, we
hypothesised that it is possible to mimic the comb-like structures
of the natural proteoglycans through non-covalent interactions
between chondroitin sulphate chains and the various peptide
analogues, therefore optimising the peptides further for this
specific application (Fig. 1). To this end, four b-sheet tape forming
peptides, systematically varying in charge (net charge of +2e
or 2e) and hydrogen bonding capacity (Glutamine (Q) or Serine
(S) based peptides) were selected and combined with GAGs
(chondroitin sulphate) (Table 1). The chondroitin sulphate struc-
ture has a 2e charge and a large number of hydrogen bond
donor (4) and acceptor (15) groups per repeat monomer unit
that will potentially facilitate interactions between the peptides
and these GAGs through a combination of electrostatic and/or
hydrogen bonding interactions. Here we demonstrate it is possible
to restore the in vitro biomechanical performance of the disc by
utilising the immense versatility of gel properties that can be
achieved. To allow direct comparison of our results with published
literature on the self-assembly of P11 peptides, the experiments
conducted in this report are all undertaken at room temperature;
the broad tunability of gel properties that we will demonstrate will
allow optimisation of the gel composition for in vivo application at
37 1C in future work.
The self-assembly behaviour, mechanical properties and in vitro
performance of peptide:GAG hybrid hydrogels are reported in
this study.
Results
The eﬀect of peptide chemistry and GAGs on self-assembly
thermodynamics and kinetics
We find that in physiological-like conditions the glutamine based
P11-4 and P11-8 have a lower residual monomer concentration
than their serine analogues P11-9 and P11-12 (Fig. 2a). This is
in agreement with our previous work that has shown that the
thermodynamics and kinetics of peptide self-assembly are strongly
dependent upon the peptide’s primary structure.26–28 Significant to
the work reported here, we showed that the glutamine-based
peptides had significantly lower critical aggregation concentrations
(c*) than their serine-based analogues. We conclude that our
selection of b-fibril forming peptide variants will be an important
control parameter for the design of the self-assembling hydrogel.
Importantly, we find that the presence of a large amount of GAG
does not inhibit P11 peptide self-assembly. NMR characterisation of
Fig. 1 Concept schematic of a peptide:GAG hybrid hydrogel as a minimally
invasive nucleus pulposus replacement.
Table 1 Peptide and GAG (chondroitin-6-sulphate) structures
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the free peptide monomer concentration that coexists in equili-
brium with the peptide fibrils (and therefore the apparent c*) is
found to decrease in the presence of GAG (Fig. 2a and Fig. S1a, ESI‡).
The cationic peptides exhibit the greater fractional decrease in c*,
with the decrease for the serine-based P11-12 being most significant.
Significantly for their application as an injectable hydrogel,
the GAG also accelerates the self-assembly and gelation kinetics
of these peptides. The thermodynamics are aﬀected by the
presence of GAG. For example with P11-12, the time for the
monomer concentration to equilibrate was within two months
with the main changes occurring in the first month, whereas with
GAG present at a peptide :GAG ratio of 1 : 5, equilibrium was
reached in less than a week (Fig. S1c, ESI‡). Visually observed
gelation times were also significantly aﬀected. For example for
P11-8 the time to gel was reduced from days to seconds, even with
a low peptide :GAG ratio of 1 : 2, demonstrating the GAG’s ability
to trigger peptide self-assembly (Fig. S1d, ESI‡). Gelation times
were also observed to be significantly reduced from days, hours,
or minutes to seconds, with P11-12 gelling instantaneously when
higher GAG ratios were used (Table S1, ESI‡).
Fourier Transform Infra-Red (FTIR) spectroscopy studies also
show that the GAGs do not inhibit the b-sheet peptide secondary
structure formation that drives the self-assembly of peptide-only
gels (Fig. 2b, c and Fig. S1b, ESI‡). In fact, the GAGs moderately
enhance the b-sheet content of the gels, with a larger increase
found for the cationic P11-8 and P11-12 peptides compared to the
anionic ones (P11-4 and P11-9). With GAG present the spectra of
all peptides are dominated by a b-sheet band at 1613 cm1 and
the weak peak at 1683–1685 cm1 implies anti-parallel arrange-
ment of the b-sheet structure that is consistent with the peptides
alone. In all spectra, a broad peak centred around 1645 cm1
coexists with the b-sheet bands suggesting the presence of
peptide in non-b-sheet state, which is expected with nucleated
self-assembly. A prominent peak centred at 1673 cm1 present in
the cationic peptide’s spectra is attributed to residual trifluoro-
acetic acid (TFA) counterions. Therefore the composite hydrogels
preserve within them the primary peptide-driven self-assembly
interactions that induce the structuring of the pure peptide
system. However, while these molecular-scale interactions are
conserved, we find significant differences in the hybrid gel
Fig. 2 Glycosaminoglycans promote b-sheet peptide fibril formation. (a) Apparent critical concentration for aggregation as determined by 1H NMR for
peptide only and peptide :GAG 1 : 10 samples, 130 mM NaCl and 1.25 mM TMSP in D2O. The table (inset) summarises the net charge and amino acid basis
of the peptides. (b) Band fitted FTIR amide I0 region of P11-8, P11-8 :GAG 1 : 10, P11-12 and P11-12 :GAG, 1 : 10, red = fitted spectra, black = processed
spectra, all other colours = various amide I0 component peaks. (c) Percentage b-sheet as determined by FTIR for peptide only and peptide :GAG 1 : 10
samples in 130 mM NaCl in D2O.
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structures on microscopic and macroscopic length scales, as we
will now show.
The eﬀect of peptide:GAG interactions on gel microstructure
We observe that incorporation of GAGs into peptide hydrogels also
modifies theirmicroscopic properties. Transmission electronmicro-
scopy images reveal pronounced diﬀerences in the fibril morphol-
ogies (Fig. 3a and Fig. S2, S3, ESI‡). Broadly speaking, the changes
in gel structure between peptide-only and peptide:GAG gels are
very similar. In peptide-only gels, the fibril widths are of the order
of 10 nm. This compares to peptide:GAG gels where the fibrils
align and cluster together with bundle diameters of the order of
100 nm. These results are quantified and presented in Table S2
(ESI‡) for each of the peptides alone and 1 : 10 peptide : GAG
mixtures.
Diﬀerences in the morphology of GAG-containing gels are
also evident on the macroscale. Hydrogels change from trans-
parent GAG-free gels to opaque gels at high GAG : peptide ratios
(Fig. 3b), implying the formation of larger aggregate structures
within GAG-containing gels that strongly scatter incident light.
We also observe the birefringence within these gels at inter-
mediate GAG concentrations, indicating the presence of nemati-
cally ordered domains (Fig. 3c). These contrasting characteristics
of gel properties in the presence of GAG further confirm the
interaction between peptides and GAGs and incorporation of
GAGs within these hydrogel structures.
The eﬀect of peptide:GAG interactions and microstructure on
gel mechanics
The specific identity of the peptide and the peptide : GAG ratio
are found to be control parameters that tune the gel mechanical
properties over an impressive range of four orders of magnitude
(Fig. 4a). Rheological measurements of these gels reveal a complex
dependence of the elastic and viscous components of the shear
moduli on the peptide : GAG ratio. However, for all samples
studied, the elastic component is found to be greater than the
viscous component, demonstrating the solid-like behaviour of
these hydrogels. All peptide:GAG gels show a typical gel profile
in the frequency sweep with the phase angle being independent
of frequency (Fig. S3, ESI‡).
The ability of peptide:GAG hydrogels to restore biomechanics
The human gel-like nucleus pulposus has been found to have an
elastic component of the shear modulus, G0, of approximately
10 kPa and a viscous component of the shear modulus, G00, of
approximately 4.5 kPa;29 this most closely matches the rheological
properties of P11-12 1 : 2 and 1 : 10 peptide :GAG ratios. Therefore,
these gels were selected for mechanical testing in the more
physiological-like conditions of a bovine caudal disc model,
although still at room temperature (Fig. 4b). Intervertebral discs
are extracted from the bovine tail and their nucleus pulpous is
removed. We attach an artificial Perspex endplate to the more
cranial disc surface and inject the hydrogel through a narrow
25 G needle, using a second 25 G needle as an airhole to prevent
build-up of internal air pressure.
Importantly, we find that we achieve successful in situ gelation
and the peptide hydrogel significantly reduces leakage of GAGs from
the caudal disc model (Fig. 4c). While 39  3% of injected GAG
leaches out of the disc after 24 hours when no peptide is present,
a 1 :10 P11-12 :GAG hydrogel reduces initial GAG leakage to 8 3%.
No further loss of GAG is observed at 48 hours, indicating that most
significant GAG outflow occurs in the first day after injection.
Fig. 3 Glycosaminoglycans induce the formation of thicker peptide fibrils. (a) TEM images showing morphology of peptide aggregates, samples with
a peptide concentration of 20 mg ml1, 130 mM NaCl in D2O, images taken at 20000 magnification, scale bars = 200 nm; top left – P11-8; top right
P11-8 :GAG 1 : 10; bottom left P11-12 and bottom right P11-12 :GAG 1 : 10. (b) Optical micrograph of gel in inverted vial from left to right P11-9, P11-9 :GAG
1 : 0.5, P11-9 :GAG 1 : 10, demonstrating self-supporting nature of gels. (c) Optical micrograph of gel in inverted vial taken through polarised lenses from
left to right P11-9, P11-9 :GAG 1 : 0.5, P11-9 :GAG 1 : 10, demonstrating birefringence of gels.
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As a first step to demonstrating the application of the hydrogel
as a minimally invasive therapy for back pain, we compare the
normalised stiﬀness of nucleated discs, denucleated discs and
denucleated discs repaired with injected 1 : 10 or 1 : 2 P11-12 :GAG
hydrogels. We demonstrate that a peptide:GAG hydrogel can
restore the biomechanics of a denucleated disc (Fig. 4d). Our
data clearly shows that both hydrogels restore the mechanical
properties of the disc towards that of a natural intact nucleus (NP).
Furthermore the 1 : 2 P11-12 :GAG hydrogel restores the biome-
chanics of a denucleated disc (No NP) to that of an intact nucleus
within the error of our measurement.
Discussion
Self-assembling peptides have potential in the application of
nucleus augmentation and to optimise them further they can be
mixed with glycosaminoglycans. By mixing them in a ratio where
there is an excess negative charge on the GAG chains e.g. 1 : 10,
1 peptide with a net overall charge of +2e and 10 GAG dimer
subunits resulting in an overall net charge of 20e, there is a
total excess of 18e net charge per peptide. This ensures there
will be a high concentration of counterions and therefore an
osmotic pressure created by the hydrogel.
Our data clearly shows that there is an interaction between
the GAG chains and the peptides. This is evidenced by faster
gelation kinetics; significantly thicker fibrils observed in the
hydrogel and enhanced mechanical properties of these gels.
The presence of GAG in the hydrogels accelerates the self-
assembly and gelation kinetics of the P11 peptides studied, with
the most dramatic eﬀect being on the positively charged peptides
where the c* was decreased by over a half. We show that the GAGs
enhance the thermodynamic stability of aggregates, increase
b-sheet content and can act as a trigger for peptide gelation.
We hypothesise, for the positively charged peptides, the anionic
GAGs locally concentrate and charge neutralise the peptides in
solution, thereby facilitating the assembly of peptide fibrils.
However, electrostatic interactions cannot be the full story in
explaining favourable peptide–GAG interactions. Other interac-
tions (e.g. hydrogen bonding between GAGs and peptides) must
play a significant role in order to explain how the GAGs also
facilitate the self-assembly of like-charged anionic peptide fibrils
(P11-4 and P11-9).
Fig. 4 Peptide:GAG hydrogels show potential to restore disc mechanics. (a) Elastic and viscous components of the shear modulus at 2 Hz (walking
frequency) for peptide and peptide:GAG samples. (b) Photographs of bovine caudal disc model preparation from the dissection of bovine tail in order to
extract discs, removal of the nucleus pulposus and artificial Perspex endplate attachment and final PEP:GAG injection through a 25 G needle with a 25 G
needle airhole. (c) Comparison of percentage of added GAG leaked from a disc over a 48 h time period when injectedwith 1 : 10 GAG only and 1 : 10 P11-12 :GAG
(error bars = SEM, n = 3 one way ANOVA carried out). (d) Plot of normalised stiﬀness for each sample type as an average of the 6 discs tested No
NP = denucleated disc, NP = intact nucleus pulposus, 1 : 10 = denucleated disc augmented with 1 : 10 P11-12 :GAG gel and 1 : 2 = denucleated disc
augmented with 1 : 2 P11-12 :GAG gel. (Error bars = SEM, n = 6, one way ANOVA carried out [unless stated diﬀerence is non-significant, *Z95%, **Z98%,
*** Z99% confidence that the means are significantly diﬀerent]).
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To confirm that indirect, depletion or excluded volume
interactions were not primarily responsible for the observed
GAG-induced enhanced gelation, we substituted non-adsorbing
polyethylene glycol (PEG) polymers of either 10 kDa or 100 kDa
molecular weight at the same mass ratio of peptide : GAG in
1 : 10 gels: we observed no comparable enhancement in gelation
kinetics as is found with the GAGs (Fig. S3, ESI‡). Therefore the
GAGs must be directly interacting with the peptides via physical
bonds to enhance their gelation.
We have confirmed that the primary structure of the peptides,
which dictates their intrinsic chemistry still plays an important
role in the peptide self-assembly with the presence of GAG, in
particular the type of polar amino acids. The peptides based on
serine side chains exhibit much higher residual monomer concen-
tration and therefore c* values for self-assembly than the peptides
based on glutamine side chains. This observation is consistent
with the polar zipper eﬀect of glutamines and is unaﬀected by the
presence of GAG.
The presence of GAGs not only aﬀects the peptide interac-
tions but also has an impact on their microscopic structure. The
diﬀerences in fibril morphologies will be expected to manifest in
notable diﬀerences in the bulk mechanical properties of these
hydrogels. The elastic modulus, or the stiﬀness of a material, is
related to the thickness of the fibrils and/or the number of
junction points between interacting fibrils, which in turn is
dependent on the density of chains, their width and length and
the cross linking aﬃnity at the junction points.30 Therefore, if any
of these factors are altered, then G0 will be altered, so a higher G0
suggests more junction points or thicker fibrils and therefore
further supports the hypothesis of the peptide and GAG chains
interacting.
In order to be a successful therapy for intervertebral disc
degeneration, the ideal peptide:GAG hydrogel should have:
 a low c*, resulting in a low level of background monomer
present and therefore minimising potential leakage from the
treatment site;
 a trigger so that the gelation occurs in situ post injection;
 a similar gel stiﬀness to that of the natural nucleus pulposus;
 a short gelation time to minimise the time of the procedure;
 a high GAG content to mimic the healthy osmotic pressure
of the nucleus;
 a good gel stability/lifetime.
The P11-12 : GAG 1 : 2 and 1 : 10 gels were chosen as the
optimum formulations from these studies because they had good
gel stability, a similar elastic modulus to that of the natural tissue
and instant in situ gelation was possible due to a trigger in the
form of the GAG addition. All these attributes are highly desirable
for application of these hydrogels in a clinical setting. Although
on its own P11-12 has a high c* and a long equilibrium time, in
the presence of chondroitin sulphate both of these key para-
meters are drastically reduced.
Following injection into a bovine disc model the presence of
P11-12 significantly reduced the percentage of GAG leaking out.
This confirmed that gelation and self-assembly were successful
within the disc and that the P11-12 aggregates were interacting
with the GAG chains to hold them in place.
The experiment in which the disc models were loaded under
static compression was designed in order to gain an initial under-
standing of how these new peptide:GAG hybrid gels compared to
the natural tissue. From the rheology investigation, the P11-12 :GAG
1 :2 gel was expected to restore the most similar biomechanics to
the natural tissue as it had the most similar elastic modulus to that
of the unconfined nucleus pulposus. Indeed, this is what we
observed, with the 1 : 2 gel performing more similarly to the
natural nucleus than the 1 : 10 gel. Encouragingly, the speci-
mens augmented with 1 : 2 gel were not significantly diﬀerent
to the intact specimens, and were significantly diﬀerent from
those with the nucleus removed. This restoration of stiﬀness
provides confidence that the peptide:GAG hydrogel has the
potential to be a successful intervertebral disc intervention.
For these highly promising injectable hydrogels to progress
towards clinical application, several key issues will need to be
addressed in future work. Tunability of the gel properties will
allow optimisation of the formulation for performance at the
physiologically relevant temperature of 37 1C. The long term
stability of these hydrogels in relevant physiological environ-
ments and hence the practical lifetime of the proposed inter-
vention will also be critical to its success. We will also test its
mechanical performance in preclinical simulations that more
closely mimic the behavior in vivo, for example in a more
physiological environment under representative cyclic loading.
Such tests should not only measure the compressive stiﬀness
of the disc, but also capture the changes in disc height and
annular bulge to gain greater evidence that the gel can provide
the necessary biomechanical performance.
Conclusions
In conclusion, we demonstrate that a peptide:GAG hydrogel can
restore the biomechanics of a denucleated intervertebral disc.
These hydrogels are injectable through a narrow gauge needle,
providing a minimally invasive method of delivering the gel into
the nucleus, where the GAG acts as a trigger for self-assembly.
We show that the GAG enhances the properties of these hybrid
gels by accelerating gelation kinetics and providing thermodyna-
mically more favourable conditions for self-assembly as demon-
strated by a significant reduction in c* and, as a result, a significant
reduction of free peptide monomer in solution. These novel
hydrogels are therefore highly promising biomaterials that could
transform surgical practice for the treatment of back pain with
substantial benefits for patient prognosis.
Experimental
Full experimental methods are described in the ESI.‡
Materials
Peptides were custom synthesised (Polypeptide group, Denmark,
NeoMPS, France or CS Bio, USA). Peptide quality control was under-
taken by the synthesis company and confirmed in-house (Table 1
and Table S3, ESI‡). The peptide content reflects non-peptide
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molecules present in the dry peptide mass; these were mainly
residual amounts of water, ammonium counterions bound on
negatively charged peptide groups and trifluoroacetic acid coun-
terions bound on positively charged groups. All peptides were
stored freeze-dried at 20 1C.
Throughout this work the terminology GAG refers to chon-
droitin sulphate sodium salt from shark cartilage (Sigma Aldrich)
and 1 :n refers to the molar ratio of one peptide to n GAG dimer
subunits (Mw 477).
Methods
1H Nuclear Magnetic Resonance spectra were recorded on a
Bruker DPX300 300 MHz spectrometer. Transmission electron
microscopy of uranyl acetate stained samples were carried out
on a Philips CM10/Jeol JEM1400 electron microscope operating
at 80/120 kV. Fourier transform infra-red spectra were acquired
with a Thermo Scientific Nicolet 6700 FTIR spectrometer.
Rheological measurements used a Malvern Kinexus Pro rheometer
with a cone-plate geometry.
Denucleated caudal discs were prepared from the tails of calves
less than 30 months old. Perspex endplates were attached with
adhesive; samples were injected through a 25 gauge (outer diameter
0.51 mm) needle. Discs were placed in phosphate buﬀered saline
solution after injection and GAG leakage was determined via a 1,9
dimethylmethylene blue assay. Static compressive loading experi-
ments were conducted on an Instron 3366 materials testing
machine with a 10 kN load cell.
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